Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06670079 · ClinicalTrials.gov registry record · NA
Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
A NA study, sponsored by University of Vermont.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06670079 is a NA study that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 30 participants.
The verdict
NCT06670079, a NA study, is actively recruiting participants, sponsored by University of Vermont.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning. Participants will: * Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.
Interventions
- BEHAVIORAL Prolonged exposure therapy + incentives for therapy session attendance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02-05 |
| Est. Completion | 2027-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06670079
The ClinicalTrials.gov registry entry for NCT06670079 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prolonged exposure therapy + incentives for therapy session attendance is the first listed.
NCT06670079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06670079 about?
NCT06670079 is a clinical study titled "Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients". The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at...
What is the current status of trial NCT06670079?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-05. Estimated completion is 2027-07-22.
What interventions are being tested in trial NCT06670079?
The interventions under investigation include: Prolonged exposure therapy + incentives for therapy session attendance (BEHAVIORAL).
Who is sponsoring clinical trial NCT06670079?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.